Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Millendo Therapeutics Inc. (MLND)

8.98   -0.14 (-1.54%) 02-21 16:00
Open: 9.14 Pre. Close: 9.12
High: 9.19 Low: 8.62
Volume: 82,423 Market Cap: 185M
Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, engages in the development of various treatments for orphan endocrine diseases in the United States. The company's lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; and nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia. Millendo Therapeutics, Inc. is headquartered in Ann Arbor, Michigan.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.21 - 9.265 9.265 - 9.306
Low: 8.493 - 8.564 8.564 - 8.616
Close: 8.885 - 8.992 8.992 - 9.072

Technical analysis

as of: 2020-02-21 4:32:04 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 11.54     One year: 13.48
Support: Support1: 7.85    Support2: 6.60
Resistance: Resistance1: 9.88    Resistance2: 11.54
Pivot: 7.84
Moving Average: MA(5): 8.89     MA(20): 7.97
MA(100): 7.46     MA(250): 10.15
MACD: MACD(12,26): 0.28     Signal(9): 0.10
Stochastic oscillator: %K(14,3): 76.12     %D(3): 76.13
RSI: RSI(14): 62.88
52-week: High: 17.34  Low: 4.56  Change(%): -21.6
Average Vol(K): 3-Month: 8885  10-Days: 13331

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MLND has closed below upper band by 17.8%. Bollinger Bands are 122.6% wider than normal. The large width of the bands suggest high volatility as compared to MLND's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Mon, 12 Aug 2019 18:11:28 +0000
Health Care Sector Update for 08/12/2019: MLND,ORGS,BLUE

Mon, 12 Aug 2019 19:47:52 +0000
Health Care Sector Update for 08/12/2019: SOLY,MLND,ORGS,BLUE

Thu, 05 Dec 2019 04:39:28 +0000
AUPH Soars On Lupus Trial Results, ACAD On Watch, ALNA Trims Workforce

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 17.64
Shares Float (M) 8.08
% Held by Insiders 10.28
% Held by Institutions 51.40
Shares Short (K) 105
Shares Short P. Month (K)

Stock Financials

EPS -3.840
Book Value (p.s.) 3.200
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.177
Qtrly Earnings Growth
Operating Cash Flow (M) -38.76
Levered Free Cash Flow (M)

Stock Valuations

P/E -2.34
P/E Growth Ratio -0.02
P/BV 2.81
P/CF -4.09

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-12-09
Last Split Ratio 0.067
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.